Browsing Tag
Otsuka Pharmaceutical
4 posts
Harbour BioMed FDA IND clearance puts HBM7004 into the clinical spotlight as bispecific oncology race intensifies
Harbour BioMed has FDA clearance, but HBM7004 must now prove whether its B7H4xCD3 design can translate platform science into clinical value.
FDA grants Otsuka’s Sibeprenlimab breakthrough therapy designation in IgAN
In a significant development for the treatment of kidney disease, the U.S. Food and Drug Administration (FDA) has…
Lupin bags tentative FDA approval for Tolvaptan Tablets, a generic of Jynarque
Lupin Limited, a global pharmaceutical powerhouse, proudly announces that it has received tentative approval from the United States…
Unichem Laboratories gets FDA approval for Aripiprazole Tablets, USP
Unichem Laboratories said that it has secured a tentative approval for abbreviated new drug application (ANDA) of Aripiprazole…